Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Livzon Pharmaceutical Group ( (HK:1513) ).
Livzon Pharmaceutical Group Inc. has announced an update to its final cash dividend for the year ending December 31, 2024, with a declared dividend of RMB 11 per 10 shares. The dividend will be paid in Hong Kong dollars at an exchange rate of RMB 1 to HKD 1.08978, with payment scheduled for July 11, 2025. This announcement reflects Livzon’s commitment to shareholder returns and may impact investor sentiment positively, reinforcing its position in the pharmaceutical market.
The most recent analyst rating on (HK:1513) stock is a Sell with a HK$24.00 price target. To see the full list of analyst forecasts on Livzon Pharmaceutical Group stock, see the HK:1513 Stock Forecast page.
More about Livzon Pharmaceutical Group
Livzon Pharmaceutical Group Inc. operates in the pharmaceutical industry, focusing on the development, production, and sale of pharmaceutical products. The company is known for its diverse range of healthcare solutions and has a market focus that includes both domestic and international stakeholders.
Average Trading Volume: 1,156,094
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$32.44B
For detailed information about 1513 stock, go to TipRanks’ Stock Analysis page.